Karen J. Wilson, SVP, Finance & PAO at Jazz Pharmaceuticals plc (JAZZ), sold 2,500 shares at $165.00 ($413K) on 2014-07-07, disclosed to the SEC on 2014-07-09.
Scheduled sale ($412k) by SVP, Finance & PAO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| JAZZ | SELL | 2018-05-15 | $620K | — | Filing → |
| JAZZ | SELL | 2018-04-12 | $604K | — | Filing → |
| JAZZ | SELL | 2017-04-27 | $204K | — | Filing → |